Selected article for: "RNA expression and small RNA expression"
Author: Cong, Wei; Zhang, Xiao-Xuan; He, Jun-Jun; Li, Fa-Cai; Elsheikha, Hany M.; Zhu, Xing-Quan
Title: Global miRNA expression profiling of domestic cat livers following acute Toxoplasma gondii infection
  • Document date: 2017_3_10
    • ID: 05tshufp_20
    Snippet: Correlation analysis of small RNA expression levels between T. gondii-infected cats of group 1 and group 2 (IL1 vs IL2); (B) Correlation analysis of small RNA expression levels between uninfected cats of group 1 and group 2 (Ul1 vs UL2). www.impactjournals.com/oncotarget modulate crucial host cellular targets needed for T. gondii replication, miRNAs may hold promise as biomarkers for prediction of disease progression. Finally, miRNA pathways that.....
    Document: Correlation analysis of small RNA expression levels between T. gondii-infected cats of group 1 and group 2 (IL1 vs IL2); (B) Correlation analysis of small RNA expression levels between uninfected cats of group 1 and group 2 (Ul1 vs UL2). www.impactjournals.com/oncotarget modulate crucial host cellular targets needed for T. gondii replication, miRNAs may hold promise as biomarkers for prediction of disease progression. Finally, miRNA pathways that are stimulated during infection may offer potential targets for therapeutic control of toxoplasmosis.

    Search related documents:
    Co phrase search for related documents
    • correlation analysis and expression level: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • disease progression and expression level: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • disease progression and potential target: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27
    • disease progression and promise hold: 1, 2, 3, 4, 5, 6
    • disease progression and therapeutic control: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • expression level and gondii infect: 1
    • expression level and infection stimulate: 1
    • expression level and miRNA pathway: 1
    • expression level and potential target: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43
    • expression level and promise hold: 1
    • expression level and therapeutic control: 1, 2
    • infection stimulate and potential target: 1
    • infection stimulate and promise hold: 1
    • miRNA pathway and potential target: 1, 2
    • potential target and promise hold: 1
    • potential target and therapeutic control: 1, 2, 3, 4, 5, 6
    • promise hold and therapeutic control: 1, 2